When we think of cancer, we often focus on the big symptoms, but colorectal cancer comes with side effects that don’t always ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Girolline, a compound extracted from the sea sponge Pseudaxinyssa cantharella, has been investigated for possible antitumor effects and also found to have anti-malarial effects. Now, researchers have ...

There is an underdiagnosed condition called statin-induced autoimmune myopathy. It can take years to show up and can be hard ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Urge your mayor to take action on climate change by joining the Earth Hour City Challenge! To avoid the worst effects of climate change, we need to dramatically reduce global carbon emissions. But we ...

When you buy through our links, we may earn a commission. Learn more› By Caira Blackwell and Joanne Chen If you’re a side-sleeper, congratulations! According to the Mayo Clinic, side sleeping ...

Lake-effect snow brings heavy snowfall to some parts of North America Lake-effect snow is most common around the Great Lakes region in the US and Canada during late autumn and winter. It can lead ...

Scientists uncover rapid-acting, low-side-effect antidepressant target New study highlights the molecular and cellular mechanisms underlying the antidepressant effect of delta opioid receptor agonists ...

This underscores the urgent need for novel, rapidly-acting therapeutic agents with minimal side effects. The delta opioid receptor (DOP) plays a key role in mood regulation, making it a promising ...

Click to share on X (Opens in new window) Click to share on LinkedIn (Opens in new window) Click to share on Facebook (Opens in new window) Click to share on Reddit (Opens in new window) Click to ...